Dr Mohamed Abdel-Daim is an associate professor of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt. He was published many manuscripts in experimental and food animals at many scientific journals related to Pharmacology, Drug Toxicology, Biochemistry, Clinical Pathology, Molecular Biology and Alternative Medicine. He is currently a member of Research Ethics Council, Academy of Scientific Research & Technology, Egypt. He has high experience in revision activities in more than 150 scientific journals.
) Pharmacology Department Suez Canal University Ismailia Egypt
Dr. Iavarone Federica is currently working as researcher in Catholic University of Sacred Heart School of Medicine. In 2010 obtained with full merit the Specialization in Clinical Biochemistry at the Medicine Faculty of the Catholic University of Sacred Heart in Rome.
Her research goals are in the field of human proteomics, in particular in the identification of biomarkers in different biological fluids as saliva and urine. She has over 50 papers published in refereed journals.
Huangxian Ju, B.S., M.S. and Ph.D in 1986, 1989 and 1992, and lecturer, associate professor and professor in 1992, 1993 and 1999 at Nanjing University, is currently the director of State Key Laboratory of Analytical Chemistry for Life Science. He won the National Funds for National Distinguished Young Scholars in 2003 and was selected as a Changjiang Professor by Education Ministry of China in 2007 and Fellows of the International Society of Electrochemistry and the Royal Society of Chemistry in 2015. He have published 632 papers, 3 English books, 7 Chinese books with >26300 citations and h-index of 84 (Google Scholar h-index 95 with 31302 citations) up to Oct 20, 2018.
) School of Chemistry and Chemical Engineering Nanjing University Nanjing China
Michele Yip-Schneider received her PhD in Biochemistry from the University of California, Davis. Following post-doctoral training at the University of California, Los Angeles and Indiana University School of Medicine, she joined the Department of Surgery faculty at Indiana University School of Medicine in 2001. Her training in molecular biology and human disease provides the foundation and expertise to pursue current translational studies in pancreatic cancer.
) Department of Surgery Indiana University School of Medicine Indianapolis, IN USA
G.R. Sridhar Endocrinology and Metabolism Endocrine and Diabetes Centre Visakhapatnam India
G. Briassoulis Department of Pediatric Intensive Care Panepistimio Kritis Rethymnon United Kingdom
T. Hayashi Department of Medical Technology International University of Health and Welfare Otawara Japan
K. Simmi Department of Biochemistry Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Sciences Rohtak India
Dr. Francesco Paolo Busardò obtained his Degree with honor in Medicine and Surgery at the University of Palermo (Italy), winning the Prize for the Best Thesis; he also got a MSc in Forensic Toxicology at the University of Glasgow (Scotland) and a PhD in Forensic Science at “Sapienza” University of Rome (Italy), where he currently works as forensic toxicologist.
He is author of more than 90 papers with I.F., with a total I.F. higher than 250 and h-index of 11.
) Department of Anatomical Histological, Forensic and Orthopaedic Sciences Sapienza University of Rome Rome Italy
Dr. Alexander E. Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as a Professor of Medicine in the State Medical University of Zaporozhye (Ukraine). His research goals are fundamental study of biological markers, the development of cardiovascular prevention and rehabilitation. Based on this research and training in heart failure he has received several awards and honors. He has published 850 papers and more in reputed journals, 27 books/chapters and has been serving as an editorial board member of repute.
) State Medical University of Zaporozhye Zaporozhye Ukraine
Dr. Chen is a pioneer in identifying biomarkers in distal body fluid of lung cancer patients by taking advantages of genetically engineered mouse model. One important goal of his lab is to predict the genotyping of the lung cancer by the biomarker information identified in patients’ urine. His research interest extends into precision medicine and driving molecular events underlying lung cancer tumorigenesis.
Dr. Matthias Hamdorf obtained his Ph.D. degree (Dr. phil. nat.) magna cum laude in 2007 from Paul Ehrlich Institute (Division of Medical Biotechnology), Langen, Germany. Since Feb 2016, Dr. Hamdorf is Research Scientist (PI) at Terasaki Research Institute, Los Angeles, CA, USA. His research and development focus is on Virology, (Retroviruses, Lentiviruses, viral vectors and Poxviruses), Cell signaling (host-virus interaction, signaling during differentiation, Cytokine signaling), Cancer research (liver, lung and melanoma), Human iPS and hematopoietic stem cells (reprogramming and differentiation), miRNA and siRNA (screening of libraries, retroviral expression of miRs/anti-miRs, target prediction), etc. Dr. Hamdorf, as an author/co-author, has published more than 15 articles in various journals, having over 525 total citations.